The Technical AnalystExchange: EURONEXT Industry: Drug Manufacturers General Specialty & Generic
Vetoquinol SA Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.91% €101.20
America/New_York / 17 mai 2024 @ 11:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 197.36 mill |
| EPS: | 4.70 |
| P/E: | 21.53 |
| Earnings Date: | Mar 20, 2024 |
| SharesOutstanding: | 11.83 mill |
| Avg Daily Volume: | 0.0033 mill |
| RATING 2024-05-17 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.22x |
| Company: PE 21.53 | sector: PE 17.68 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.86x |
| Company: PE 21.53 | industry: PE 11.60 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€63.32 (-37.43%) €-37.88 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
€ 98.92 - 103.48 ( +/- 2.26%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €101.20 (1.91% ) |
| Volume | 0.0031 mill |
| Avg. Vol. | 0.0033 mill |
| % of Avg. Vol | 96.06 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For VETO.PA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
VETO.PA
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.